SS-31
What is SS-31?
SS-31 (also known as Elamipretide) is a breakthrough mitochondria-targeted peptide designed to protect and repair cells at their energy source. Mitochondria are the “powerhouses”of your cells, responsible for producing energy. As we age, mitochondrial function declines, leading to fatigue, muscle weakness, and faster progression of age-related conditions. SS-31 binds to the inner mitochondrial membrane, improving energy production and reducing oxidative stress.
Why SS-31 Therapy?
Patients often ask why SS-31 is different from other anti-aging or peptide therapies. Unlike treatments that only work on the surface, SS-31:
- Directly targets mitochondria to improve cellular energy output energy metabolism
- Protects cells from oxidative stress (free radical damage)
- Slows age-related cellular decline
- Has been studied for heart, kidney, muscle, and neurodegenerative health
Potential Benefits
Improved energy and stamina.
Better exercise tolerance and muscle recovery.
Support for cardiovascular and kidney function.
Neuroprotective effects, supporting brain health and cognition.
Anti-aging at the cellular level, slowing mitochondrial decline.
FAQs
Is it safe?
Research and clinical trials suggest SS-31 is generally well tolerated, with a good safety profile.
At our clinic, therapy is provided under medical supervision and tailored to each patient’s needs.
Who is it for?
- Individuals with chronic fatigue or low energy.
- Patients seeking anti-aging and longevity support.
- Those with cardiovascular, muscular, or metabolic concerns.
- Individuals looking for cutting-edge regenerative therapies.
How is it administered?
SS-31 is typically given as an intravenous infusion or subcutaneous injection, depending on treatment goals.
How soon will I feel results?
Some patients report improved energy within days to weeks, while others notice more gradual benefits with ongoing sessions.
Can it be combined with other therapies?
Yes — SS-31 can complement other regenerative treatments such as NMN, NAD+, or stem cell-based therapies for enhanced results
